Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 7:49 PM
Ignite Modification Date: 2025-12-25 @ 5:25 PM
NCT ID: NCT05074303
Description: None
Frequency Threshold: 0
Time Frame: 42 days
Study: NCT05074303
Study Brief: Beta-glucan and Immune Response to Influenza Vaccine
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Placebo 500 mg/day cellulose Influenza Vaccine: All subjects will receive the influenza vaccine. Placebo: 2 - 250 mg capsules/day of cellulose 0 None 0 40 0 40 View
Beta-glucan 500 mg/day beta-glucan Influenza Vaccine: All subjects will receive the influenza vaccine. Beta-glucan: 2 - 250 mg capsules/day of beta-glucan derived from Baker's yeast 0 None 0 38 0 38 View
Serious Events(If Any):
Other Events(If Any):